Cargando…

Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis

Background: Pulmonary arterial hypertension (PAH) is a severe and fatal clinical syndrome characterized by high blood pressure and vascular remodeling in the pulmonary arterioles, which is also a rapidly progressing disease of the lung vasculature with a poor prognosis. Although PAH medication made...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Wenhai, He, Wenjun, Li, Yuexin, Chen, Yangxiao, Liang, Jingyi, Lei, Hui, Fu, Lin, Chen, Yanghang, Ren, Ni, Jiang, Qian, Shen, Yi, Ma, Ran, Wang, Tao, Wang, Xinni, Zhang, Nuofu, Xiao, Dakai, Liu, Chunli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172220/ https://www.ncbi.nlm.nih.gov/pubmed/34060401 http://dx.doi.org/10.1080/10717544.2021.1927243

Ejemplares similares

Efficacy and Safety of Rivaroxaban versus Warfarin for the Treatment of Acute Pulmonary Embolism: A Real-World Study
por: Huang, Yan, et al.
Publicado: (2020)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
por: Wu, Yanjuan, et al.
Publicado: (2023)

Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study
por: Chen, Yuqin, et al.
Publicado: (2019)

Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study
por: Chen, Yuqin, et al.
Publicado: (2020)

Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?
por: Zheng, Zhenzhen, et al.
Publicado: (2021)

A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension
por: Wang, Sumei, et al.
Publicado: (2018)

Pulmonary Vasculature: A Target for COVID-19
por: Chen, Lingdan, et al.
Publicado: (2021)

BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Chen, Lingdan, et al.
Publicado: (2020)

Role of macrophages in pulmonary arterial hypertension
por: Zhang, Meng-Qi, et al.
Publicado: (2023)

The impact of the COVID‐19 pandemic on the care of pulmonary hypertension patients outside the Hubei province in China
por: Chen, Yuqin, et al.
Publicado: (2022)

Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters
por: Wang, Tao, et al.
Publicado: (2010)

Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2020)

Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
por: Ding, Mingge, et al.
Publicado: (2015)

Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis
por: Li, Hong-Yan, et al.
Publicado: (2023)

TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients
por: He, Wenjun, et al.
Publicado: (2022)

Input Forces Estimation for Nonlinear Systems by Applying a Square-Root Cubature Kalman Filter
por: Song, Xuegang, et al.
Publicado: (2017)

Load Identification for a Cantilever Beam Based on Fiber Bragg Grating Sensors
por: Song, Xuegang, et al.
Publicado: (2017)

Positron Emission Tomography: A Novel Approach to Detect Pulmonary Artery Hypertension at the Early Stage?
por: Tang, Ruidi, et al.
Publicado: (2020)

Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta‐analysis
por: Wang, Wuwan, et al.
Publicado: (2019)

Safety and tolerability of bosentan in the management of pulmonary arterial hypertension
por: Roberts, Kari E, et al.
Publicado: (2009)

Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension
por: Wu, Yan, et al.
Publicado: (2022)

Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization
por: Li, Qiangqiang, et al.
Publicado: (2022)

EnRank: An Ensemble Method to Detect Pulmonary Hypertension Biomarkers Based on Feature Selection and Machine Learning Models
por: Liu, Xiangju, et al.
Publicado: (2021)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
por: Wang, Tao, et al.
Publicado: (2020)

Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update
por: Wong, Alexandra K, et al.
Publicado: (2019)

‘Two-step’ percutaneous procedure for repairing the atrial septal defect with severe pulmonary hypertension: a case report
por: Fu, Liang, et al.
Publicado: (2023)

Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China
por: Hong, Cheng, et al.
Publicado: (2023)

Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial
por: Chen, Yuqin, et al.
Publicado: (2021)

Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension
por: Hao, Mingwen, et al.
Publicado: (2017)

Mitochondrial Fission-Mediated Lung Development in Newborn Rats With Hyperoxia-Induced Bronchopulmonary Dysplasia With Pulmonary Hypertension
por: Dai, Yuanyuan, et al.
Publicado: (2021)

The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
por: Shu, Tingting, et al.
Publicado: (2021)

Comparative Transcriptional Analysis of Pulmonary Arterial Hypertension Associated With Three Different Diseases
por: Wang, Wei, et al.
Publicado: (2021)

Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
por: Dodgen, Andrew L, et al.
Publicado: (2015)

Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension
por: Monaco, Thomas J, et al.
Publicado: (2016)

Real role of β-blockers in regression of left ventricular mass in hypertension patients: Bayesian network meta-analysis
por: Xing, FuWei, et al.
Publicado: (2017)

Case Report: The First Case of Bloodstream Infection Complicated with Psoas Abscess and Pulmonary Infection Caused by Aggregatibacter aphrophilus in China
por: Lu, Bin, et al.
Publicado: (2022)

Updated perspective of EPAS1 and the role in pulmonary hypertension
por: Wang, Na, et al.
Publicado: (2023)

Efficacy and Safety of Treatments for Patients With Portal Hypertension and Cirrhosis: A Systematic Review and Bayesian Network Meta-Analysis
por: Yao, Qigu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjsklgb3e7l642uqchh68u71od